| Sanofi-Aventis (Suisse) SA - Tetravac, suspension injectable | | 00612 | | 01 | | Tetravac | | suspension injectable | | J07CA02 | | Diphtherie-Pertussis-Poliomyelitis-Tetanus | | 18.08.1999 | | |
| | Zusammensetzung | | toxoidum diphtheriae 20 U.I., toxoidum tetani 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, ethanolum 2 mg, phenoxyethanolum, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: glutaralum, neomycinum, streptomycinum, polymyxinum B. | | Packungsbestandteile | | Injektionssuspension | | | | | | | | Wirkstoffe | Stärke |
|---|
| Toxoidum Diphtheriae | 20 UI | | Toxoidum Tetani | 40 UI |
| | BAG: Wirkstoffe | Stärke |
|---|
| Toxoidum Diphtheriae | 20 UI | | Toxoidum Pertussis | 25 mcg | | Toxoidum Tetani | 40 UI | | Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III) | 62 U |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| Acidum Aceticum Glaciale | | | | Aluminium | 0.3 mg | | | Cum Phenylalaninum | 12.5 µg | | | Ethanol | 2 mg | | | Formaldehydum | | | | Haemagglutininum Filamentosum | 25 µg | | | Inactivatus | 26 U | | | Kalium | | | | Medium | 199 | | | Phenoxyethanolum | | | | Toxoidum Pertussis | 25 µg | bordetellae pertussis antigenum | | Virus Poliomyelitis Typus | 3 | |
| |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 003 | | 20.21 | 38.40 | B | SL | Nein |
|
|
